41
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Next-generation sequencing of the hypervariable V3 region of the 16s rRNA gene isolated from serial stool specimens collected from 31 patients receiving allogeneic stem cell transplantation (SCT) was performed to elucidate variations in the composition of the intestinal microbiome in the course of allogeneic SCT. Metagenomic analysis was complemented by strain-specific enterococcal PCR and indirect assessment of bacterial load by liquid chromatography-tandem mass spectrometry of urinary indoxyl sulfate. At the time of admission, patients showed a predominance of commensal bacteria. After transplantation, a relative shift toward enterococci was observed, which was more pronounced under antibiotic prophylaxis and treatment of neutropenic infections. The shift was particularly prominent in patients that developed subsequently or suffered from active gastrointestinal (GI) graft-versus-host disease (GVHD). The mean proportion of enterococci in post-transplant stool specimens was 21% in patients who did not develop GI GVHD as compared with 46% in those that subsequently developed GI GVHD and 74% at the time of active GVHD. Enterococcal PCR confirmed predominance of Enterococcus faecium or both E. faecium and Enterococcus faecalis in these specimens. As a consequence of the loss of bacterial diversity, mean urinary indoxyl sulfate levels dropped from 42.5 ± 11 μmol/L to 11.8 ± 2.8 μmol/L in all post-transplant samples and to 3.5 ± 3 μmol/L in samples from patients with active GVHD. Our study reveals major microbiome shifts in the course of allogeneic SCT that occur in the period of antibiotic treatment but are more prominent in association with GI GVHD. Our data indicate early microbiome shifts and a loss of diversity of the intestinal microbiome that may affect intestinal inflammation in the setting of allogeneic SCT.

          Related collections

          Author and article information

          Journal
          Biol Blood Marrow Transplant
          Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
          Elsevier BV
          1523-6536
          1083-8791
          May 2014
          : 20
          : 5
          Affiliations
          [1 ] Department of Hematology/Oncology, University Medical Center, Regensburg, Germany. Electronic address: ernst.holler@ukr.de.
          [2 ] Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
          [3 ] Department of Hematology/Oncology, University Medical Center, Regensburg, Germany.
          [4 ] Institute of Microbiology, University Medical Center, Regensburg, Germany.
          [5 ] Institute of Immunology, University of Regensburg, Regensburg, Germany.
          [6 ] University of Michigan Medical Center, Blood and Marrow Transplantation Program, Ann Arbor, Michigan.
          Article
          S1083-8791(14)00075-5 NIHMS803398
          10.1016/j.bbmt.2014.01.030
          4973578
          24492144
          1d8c671e-2105-48de-99b0-f498a0df4e69
          Copyright © 2014 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
          History

          Clinical allogeneic transplantation,GVHD,Metagenomics,Microbiome

          Comments

          Comment on this article